Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02083861 · ClinicalTrials.gov registry record · NA
Wearable LITUS Device for Osteoarthritis of the Knee: a Randomized Double-Blind Placebo-Controlled Trial
A NA study, sponsored by ZetrOZ.
- Completed
- Registry status
- NA
- Development phase
- 93
- Enrollment target
NCT02083861 is a NA study that has completed, run by ZetrOZ. The registered enrollment target is 93 participants.
The verdict
NCT02083861, a NA study, has completed, sponsored by ZetrOZ.
- COMPLETED
- Registry status
- NA
- Development phase
- 93 participants
- Enrollment target
Study Summary
The purpose of this study is to measure the effectiveness of a wearable therapeutic ultrasound device in patients with stage I and stage II knee osteoarthritis. The ability of the device to reduce pain, increase mobility, increase range of motion and muscle strength of the affected leg, and improve quality of life in patients with knee osteoarthritis will be evaluated.
Interventions
- DEVICE Sam Ultrasonic Diathermy Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2014-03 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02083861
The ClinicalTrials.gov registry entry for NCT02083861 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ZetrOZ, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sam Ultrasonic Diathermy Device is the first listed.
NCT02083861 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02083861 about?
NCT02083861 is a clinical study titled "Wearable LITUS Device for Osteoarthritis of the Knee: a Randomized Double-Blind Placebo-Controlled Trial". The purpose of this study is to measure the effectiveness of a wearable therapeutic ultrasound device in patients with stage I and stage II knee osteoarthritis. The ability of the device to reduce pain, increase mobility, increase range of motion and muscle strength of the affected leg, and improve ...
What is the current status of trial NCT02083861?
This trial is currently completed. It is a NA study. The enrollment target is 93 participants. The study started on 2014-03. Estimated completion is 2014-10.
What interventions are being tested in trial NCT02083861?
The interventions under investigation include: Sam Ultrasonic Diathermy Device (DEVICE).
Who is sponsoring clinical trial NCT02083861?
This trial is sponsored by ZetrOZ, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.